SNDL Revenue 2020-2024 | SNDL
SNDL revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| SNDL Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $672 |
| 2023 | $673 |
| 2022 | $548 |
| 2021 | $45 |
| 2020 | $45 |
| 2019 | $57 |
| 2018 | $0 |
| SNDL Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-12-31 | $185 |
| 2024-09-30 | $174 |
| 2024-06-30 | $167 |
| 2024-03-31 | $147 |
| 2023-12-31 | $165 |
| 2023-09-30 | $177 |
| 2023-06-30 | $182 |
| 2023-03-31 | $150 |
| 2022-12-31 | $182 |
| 2022-09-30 | $177 |
| 2022-06-30 | $175 |
| 2022-03-31 | $14 |
| 2021-12-31 | $18 |
| 2021-09-30 | $11 |
| 2021-06-30 | $7 |
| 2021-03-31 | $8 |
| 2020-12-31 | $4 |
| 2020-09-30 | $10 |
| 2020-06-30 | $15 |
| 2020-03-31 | $17 |
| 2019-12-31 | $16 |
| 2019-09-30 | $25 |
| 2019-06-30 | $14 |
| 2019-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.344B | $0.672B |
| SNDL INC. is a private sector cannabis and liquor retailer principally in Canada. The company's operated and reported segment includes Cannabis Production and Cultivation, Cannabis Retail, Liquor Retail and Investments. Its retail banners include Spiritleaf, Value Buds, Wine and Beyond, Liquor Depot and Ace Liquor. SNDL INC., formerly known as Sundial Growers Inc., is based in CALGARY, AB. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.138B | 28.03 |
| Boston Scientific (BSX) | United States | $152.812B | 38.26 |
| Stryker (SYK) | United States | $145.981B | 30.52 |
| EssilorLuxottica (ESLOY) | France | $128.807B | 0.00 |
| Medtronic (MDT) | Ireland | $107.246B | 15.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.937B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.673B | 27.10 |
| ResMed (RMD) | United States | $35.644B | 26.77 |
| GE HealthCare Technologies (GEHC) | United States | $32.281B | 15.33 |
| Agilent Technologies (A) | United States | $30.991B | 20.47 |
| Terumo (TRUMY) | Japan | $28.175B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.624B | 16.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.817B | 12.09 |
| Insulet (PODD) | United States | $18.083B | 70.99 |
| Baxter (BAX) | United States | $16.011B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.962B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.751B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 14.04 |
| Prestige Consumer Healthcare (PBH) | United States | $4.312B | 19.21 |
| Perrigo (PRGO) | Ireland | $3.684B | 9.34 |
| ICU Medical (ICUI) | United States | $3.516B | 25.93 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.417B | 14.88 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.459B | 16.96 |
| GN Store Nord (GNNDY) | Denmark | $2.020B | 16.73 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| Neogen (NEOG) | United States | $1.300B | 16.64 |
| Green Thumb Industries (GTBIF) | United States | $1.234B | 27.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.162B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.130B | 11.47 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| InMode (INMD) | Israel | $0.990B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.901B | 11.53 |
| Evolus (EOLS) | United States | $0.651B | 0.00 |
| CeriBell (CBLL) | United States | $0.616B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.592B | 0.00 |
| Owens & Minor (OMI) | United States | $0.540B | 4.48 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.389B | 0.00 |
| Omeros (OMER) | United States | $0.368B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.356B | 13.11 |
| Capricor Therapeutics (CAPR) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 47.50 |
| Verano Holdings (VRNOF) | United States | $0.266B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.256B | 11.63 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.205B | 5.75 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 52.18 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.33 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 58.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.74 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |